drugset / Trial / NCT00439608

Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer

NCT00439608 ↗

Phase 2 Completed 60 enrolled Brown University Bristol-Myers Squibb · collab
NaSingle-groupOpen-labelTreatment

Summary

Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer

Timeline

Start
2004-10
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Cetuximab Monoclonal antibody — Intravenous
Subject Paclitaxel Small molecule — Intravenous